✦ LIBER ✦

Evaluation of the efficacy and tolerability of two different dosages of fenticonazole vaginal ovules (600 mg and 1000 mg) in patients with vaginal trichomoniasis: A controlled, double-blind, randomized clinical trial versus placebo

✍ Scribed by F. Gorlero; S. Macchiavello; L. Pellegatta; M.L. Airoldi; B. Gaffuri; L. Pulici; L. De Cecco

Book ID: 117090475
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 529 KB
Volume: 55
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(05)80181-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

(774): A multi-center, randomized, doubl

(774): A multi-center, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide (200, 400, and 600mg/day) in subjects with painful distal diabetic neuropathy

✍ P. Kenney; J. Simpson; B. Koch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A multicentre, double-blind, randomized,

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy

✍ T Betts; T Waegemans; P Crawford 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Efficacy and Tolerability of a 20-mg Dos

Efficacy and Tolerability of a 20-mg Dose of Methylphenidate for the Treatment of Daytime Sleepiness in Adult Patients With Myotonic Dystrophy Type 1: A 2-Center, Randomized, Double-Blind, Placebo-Controlled, 3-Week Crossover Trial

✍ Jack Puymirat; Jean-Pierre Bouchard; Jean Mathieu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A Multicenter, Prospective, Randomized,

A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)

✍ Jani, Rajendrakumar H.; Pai, Vikas; Jha, Pramod; Jariwala, Gunjan; Mukhopadhyay, 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 365 KB